Table 6.
Number of questions asked during the video encounters, according to type of question and cycle.
| Cycle and question type | Median number of questions asked by patient (interquartile range) | Maximum | ||
| 1 (n=56) |
|
|
|
|
|
|
Drug administration | 2 (1-4) | 10 | |
|
|
Drug handling | 0 (0-1) | 4 | |
| Research team contact | 0.5 (0-1) | 3 | ||
| Scheduling | 1 (0.5-2) | 8 | ||
| Side effects | 1 (0-3.5) | 8 | ||
| Webpage | 0 (0-0) | 2 | ||
| 2 (n=52) |
|
|
|
|
|
|
Drug administration | 0 (0-1) | 7 | |
| Drug handling | 0 (0-0) | 4 | ||
| Research team contact | 0 (0-0) | 6 | ||
| Scheduling | 0 (0-1) | 3 | ||
| Side effects | 0 (0-1) | 5 | ||
| Webpage | 0 (0-0) | 2 | ||
| 3 (n=44) |
|
|
|
|
|
|
Drug administration | 0 (0-2) | 4 | |
| Drug handling | 0 (0-0) | 5 | ||
| Research team contact | 0 (0-0) | 1 | ||
| Scheduling | 0 (0-1) | 7 | ||
| Side effects | 1 (0-2) | 7 | ||
| Webpage | 0 (0-0) | 1 | ||
| 4 (n=43)a |
|
|
|
|
|
|
Drug administration | 0 (0-1) | 4 | |
| Drug handling | 0 (0-0) | 4 | ||
| Research team contact | 0 (0-0) | 1 | ||
| Scheduling | 0 (0-1) | 3 | ||
| Side effects | 1 (0-2) | 7 | ||
| Webpage | 0 (0-0) | 2 | ||
aData missing on 1 patient.